Sample of Recently Noted Publications

Queen’s Urology is one of the most academically successful departments in Canada and, per capita, boasts the greatest research output of all the clinical Departments in the Faculty of Health Sciences at Queen’s University.

The Department has a long history of successful extra-mural, peer-reviewed industry grants and trials spanning interests in basic science, chronic pain, voiding function and health outcomes research.

Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS.

Saar M, Fizazi K, Shore ND, Smith M, Damber JE, Semenov A, Ribal MJ, Birtle A, Rigaud J, Wallis CJD, Grimm MO, Halabi S, Armstrong AJ, Mohamed AF, Adorjan P, Srinivasan S, Verholen F, Morgans AK, Siemens DR.

Cancer Med. 2026

Imaging Mass Cytometry Immune Profiling of Hunner Lesions in a Convenience Sample of Patients With Interstitial Cystitis/Bladder Pain Syndrome.

Cotechini T, Kim N, Hindmarch CCT, Berman DM, Nickel JC, Siemens DR, Simpson AL, Doiron RC.

J Urol. 2026

The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women: A cost-utility analysis.

Doiron RC, Nickel JC, Kamdar S.

Can Urol Assoc J. 2026

The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative.

Terry Fox Research Institute Marathon of Hope Cancer Centers Network. Electronic address: mmarra@bcgsc.ca; Terry Fox Research Institute Marathon of Hope Cancer Centers Network.

Cancer Cell. 2025

Artificial Intelligence as a Discriminator of Competence in Urological Training: Are We There?

Touma NJ, Patel R, Skinner T, Leveridge M.

J Urol. 2025

Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach.

Lai HH, Pontari MA, Argoff CE, Bresler L, Breyer BN, Chou R, Clemens JQ, De EJB, Doiron RC, Johnson D, Kirkby E, MacDonald SM, Osborne JH, Parekattil SJ, Shelly B.

J Urol. 2025

The learning styles of graduating Canadian urology residents.

Moreno NV, Dhatt J, Touma NJ.

Can Urol Assoc J. 2025

Development of a reoperative risk prediction model of muscle-invasive upper tract urothelial carcinoma using clinical and radiomic computed tomography features: Initial results from a multi-institutional Canadian study.

Nguyen DD, Nasute Fauerbach PV, Kwong JCC, McLoughlin L, Lajkosz K, Al-Rumayyan M, Alam A, Fugaru I, St-Laurent MP, Toren P, Fradet V, Rendon RA, Siemens DR, Breau RH, Kassouf W, Black PC, Kulkarni GS, Haider MA.

Can Urol Assoc J. 2025

Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non-Muscle Invasive Bladder Cancer.

Yolmo P, Rahimi S, Chenard S, Conseil G, Jenkins D, Sachdeva K, Emon I, Hamilton J, Xu M, Rangachari M, Michaud E, Mansure JJ, Kassouf W, Berman DM, Siemens DR, Koti M.

Cancer Immunol Res. 2024

Understanding the sleep-pain relationship in patients with interstitial cystitis/bladder pain syndrome.

Kelly AA, Jones K, Pineau O, Nickel JC, Rose J, Moldwin R, Doiron C, Riedl C, Cervigni M, Wyndaele J, Tripp A.

Can Urol Assoc J. 2024

Adaptive Immunity in Genitourinary Cancers.

Koti M, Bivalacqua T, Black PC, Cathomen T, Galsky MD, Gulley JL, Ingersoll MA, Kamat AM, Kassouf W, Siemens DR, Gao J.

Eur Urol Oncol. 2023

Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.

Berman DM, Lee AY, Lesurf R, Patel PG, Ebrahimizadeh W, Bayani J, Lee LA, Boufaied N, Selvarajah S, Jamaspishvili T, Guérard KP, Dion D, Kawashima A, Clarke GM, How N, Jackson CL, Scarlata E, Siddiqui K, Okello JBA, Aprikian AG, Moussa M, Finelli A, Chin J, Brimo F, Bauman G, Loblaw A, Venkateswaran V, Buttyan R, Chevalier S, Thomson A, Park PC, Siemens DR, Lapointe J, Boutros PC, Bartlett JMS.

J Urol. 2023

Real-life benchmarking bladder cancer care: A population-based study.

Vanin Moreno N, Whitehead M, Siemens DR.

Can Urol Assoc J. 2023

The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer: A RADICAL-PC Analysis.

Klimis H, Pinthus JH, Aghel N, Duceppe E, Fradet V, Brown I, Siemens DR, Shayegan B, Klotz L, Luke PP, Niazi T, Lavallee LT, Mousavi N, Hamilton RJ, Chin JL, Gopaul D, Violette PD, Davis MK, Hanna N, Sabbagh R, Ben Zadok OI, Hajjar LA, Kann AG, Mian R, Rangarajan S, Huei Ng KK, Iakobishvili Z, Selvanayagam JB, Avezum A, Leong DP.

JACC CardioOncol. 2023

Association of Histone H3 Trimethylation in Circulating Monocytes with Lack of Early Recurrence in Patients with Bladder Cancer following BCG Induction Therapy.

Paré JF, Tabasinezhad M, Grossman A, Atallah A, Hindmarch CCT, Tyryshkin K, Siemens DR, Graham CH.

Bladder Cancer. 2023